Frans Van de Werf Selected Research

Frans Van de Werf Research Topics

Disease

111	Myocardial Infarction 10/2019 - 01/2002
70	Acute Coronary Syndrome 07/2021 - 01/2002
58	ST Elevation Myocardial Infarction 01/2021 - 04/2002
51	Hemorrhage 01/2020 - 01/2002
32	Stroke (Strokes) 10/2019 - 02/2005
28	Heart Failure 01/2018 - 05/2002
25	Infarction (Infarctions) 01/2018 - 12/2002
14	Ischemia 03/2017 - 02/2004
11	Thrombosis (Thrombus) 11/2018 - 08/2003
7	Type 2 Diabetes Mellitus (MODY) 10/2018 - 07/2015
7	Unstable Angina 01/2018 - 07/2002
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 06/2002
7	Inflammation (Inflammations) 04/2007 - 05/2004
7	Left Ventricular Dysfunction 03/2007 - 08/2003
6	Vascular Diseases (Vascular Disease) 11/2020 - 07/2003
5	Shock 01/2021 - 01/2007
5	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2020 - 04/2003
5	Myocardial Ischemia (Ischemic Heart Diseases) 04/2015 - 07/2006
4	Cardiogenic Shock 01/2021 - 04/2007
4	Body Weight (Weight, Body) 01/2018 - 07/2003
4	Diabetes Mellitus 11/2017 - 08/2006
4	Atrial Fibrillation 09/2013 - 10/2006
4	Coronary Artery Disease (Coronary Atherosclerosis) 03/2012 - 06/2002
3	Chronic Obstructive Pulmonary Disease (COPD) 12/2019 - 12/2015
3	Coronary Disease (Coronary Heart Disease) 01/2019 - 04/2006
3	Reperfusion Injury 04/2015 - 05/2004
2	Non-ST Elevated Myocardial Infarction 12/2019 - 01/2018
2	Hemorrhagic Stroke 12/2018 - 12/2017
2	Sudden Death 11/2018 - 06/2005
2	Hypertension (High Blood Pressure) 11/2017 - 02/2010
2	Peripheral Arterial Disease 12/2015 - 10/2014
2	Necrosis 07/2013 - 08/2006
2	Transient Ischemic Attack 01/2011 - 02/2010
2	Ventricular Fibrillation 01/2011 - 12/2008
2	Ventricular Tachycardia 01/2011 - 12/2008

Drug/Important Bio-Agent (IBA)

21	vorapaxarIBA 12/2018 - 03/2009
19	Glycoproteins (Glycoprotein)IBA 01/2018 - 01/2002
17	Thrombin Receptors (Thrombin Receptor)IBA 12/2018 - 11/2010
14	Tenecteplase FDA Link 01/2020 - 04/2003
14	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2018 - 06/2002
12	Eptifibatide (Integrilin)FDA Link 04/2014 - 07/2002
12	pexelizumabIBA 07/2012 - 03/2005
10	CreatinineIBA 12/2019 - 07/2003
10	Enoxaparin (Lovenox)FDA LinkGeneric 07/2013 - 04/2002
9	Sitagliptin Phosphate (Januvia)FDA Link 11/2020 - 07/2015
9	Heparin (Liquaemin)FDA LinkGeneric 05/2011 - 08/2002
8	Valsartan (Vals)FDA Link 06/2009 - 08/2003
7	Pharmaceutical PreparationsIBA 01/2021 - 01/2002
7	Clopidogrel (Plavix)FDA Link 12/2014 - 04/2008
6	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2020 - 07/2003
6	Peptide Hydrolases (Proteases)FDA Link 12/2018 - 08/2006
6	Platelet Membrane Glycoprotein IIbIBA 02/2016 - 10/2002
5	Biomarkers (Surrogate Marker)IBA 01/2019 - 06/2004
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 05/2004
5	Captopril (Capoten)FDA LinkGeneric 03/2007 - 08/2003
5	Platelet Membrane GlycoproteinsIBA 07/2005 - 01/2002
5	Abciximab (ReoPro)FDA Link 04/2005 - 11/2002
4	AnticoagulantsIBA 01/2021 - 11/2005
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2015 - 07/2003
4	PAR-1 ReceptorIBA 12/2015 - 10/2012
4	MetalsIBA 09/2014 - 04/2008
4	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2010 - 07/2005
4	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 09/2007 - 10/2002
4	Complement System Proteins (Complement)IBA 01/2007 - 02/2006
3	Blood Glucose (Blood Sugar)IBA 12/2019 - 02/2009
3	TicagrelorIBA 10/2019 - 04/2016
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018 - 01/2016
3	omega-Chloroacetophenone (Mace)IBA 01/2018 - 04/2016
3	Dabigatran FDA Link 09/2013 - 11/2011
3	Warfarin (Coumadin)FDA LinkGeneric 09/2013 - 08/2009
3	CytokinesIBA 07/2013 - 03/2005
3	Streptokinase FDA Link 01/2011 - 07/2002
3	Nitric Oxide Synthase (NO Synthase)IBA 03/2010 - 05/2004
3	Creatine Kinase (Creatine Phosphokinase)IBA 01/2009 - 02/2007
3	sibrafibanIBA 08/2007 - 08/2003
3	Complement C5 (Complement 5)IBA 09/2006 - 08/2006
3	paragonIBA 02/2003 - 07/2002
2	DiureticsIBA 12/2019 - 12/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 02/2009
2	Hemoglobins (Hemoglobin)IBA 01/2019 - 12/2015
2	Troponin T (Troponin T1)IBA 01/2018 - 02/2003
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2017 - 08/2006
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2017 - 07/2003
2	Prasugrel Hydrochloride FDA Link 02/2016 - 04/2008
2	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2016 - 07/2015
2	TroponinIBA 06/2015 - 07/2013
2	AntithrombinsIBA 09/2013 - 04/2002
2	Syndecan-1 (Syndecan 1)IBA 07/2013 - 01/2007

Therapy/Procedure

68	Therapeutics 07/2021 - 01/2002
47	Percutaneous Coronary Intervention 01/2021 - 10/2002
16	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 11/2018 - 05/2004
11	Stents 11/2018 - 08/2003
9	Patient Readmission 01/2018 - 01/2012
9	Thrombolytic Therapy 02/2016 - 11/2002
6	Secondary Prevention 12/2019 - 08/2003
5	Drug-Eluting Stents 09/2014 - 09/2006
3	Length of Stay 01/2018 - 02/2004
2	Duration of Therapy 01/2017 - 01/2013
2	Blood Transfusion (Blood Transfusions) 07/2013 - 01/2008
2	Intravenous Administration 04/2011 - 01/2007